Vifor Pharma Stock Price, News & Analysis
Company Description
Vifor Pharma (OTC: GNHAY) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector. The company has a market capitalization of $12.5B.
GNHAY stock has gained 8.2% over the past year.
This page provides a comprehensive overview of GNHAY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Vifor Pharma (GNHAY) stock. Over the past 12 months, the stock has gained 8.2%. At a market capitalization of $12.5B, GNHAY is classified as a large-cap stock with approximately 324.5M shares outstanding.
Latest News
Vifor Pharma has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include acquisition. View all GNHAY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
GNHAY Company Profile & Sector Positioning
Vifor Pharma (GNHAY) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.